Arkolith/Insider Trading/AQST/Form 4

Jung Cassie

Chief Operating OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Oct 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$474K
Net Open-Market Flow
-$474K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Sell(S)68K$7.01$474K241K
Oct 15, 2025Option exercise(M)25K$3.10$78K308K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2025Option exercise(M)25K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-015048) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML